PRODUCT LIST

RELATED PRODUCTS

Download CATALOGUE

Position:HOME > Product

Chlormadinone Acetate

Payment
T/T, west union, money gram,paypal
Delivery
within 3-5 working days
Origin
China
Packaging
1kg/bag or as required
Inspection
HPLC,UV
Samples
Free
COA
sales@nitobioc.com
Purity
98%
Standard
JP 14/CP 2005/ES

Product Description
Chlormadinone acetate (CMA) is a derivative of progesterone, first synthesized in 1961 and is used as an orally effective progestogen in hormone replacement therapy (HRT), and in combination with ethinyl estradiol (EE) in contraception since 1999. Chlormadinone acetate has a strong progestogenic effect - about one-third higher than that of progesterone - and may vary depending on the previous effect of an estrogen, i.e., estrogens may promote the formation of progesterone receptors and proliferation of the endometrium. Like progesterone, it is anti-estrogenic and has no partial androgenic effect (at the doses used for contraception and HRT). In contrast to progesterone, it has a slight glucocorticoid effect, a pronounced anti-androgenic effect and no anti-mineralocorticoid effect. No pregnancy-maintaining effect of CMA has been demonstrated in humans.
 

NITO Safe Delivery
---- SAFTY COMES FIRST !
Considering steroids are very special in some countries, NITO will supply professional suggestion for package+label+documents+transport mode, to ensure goods arrive safely and smoothly without and trouble.
 
Product Feature
Product name: Dienogestrel
English Name: 17-Acetoxy-6-chloro-6-dehydroprogesterone
CAS: 302-22-7
Formula: C23H29ClO4
MW: 404.93

Product Specification / Models
Purity: 99%min
Appearance:white powder.
Packing: 1kg/bag or as required.
Storage: Store in cool and dry area and keep away from direct sunlight.
Shelf life: 2 years, if keep in formal storage condition.
 
Application
The anti-androgenic effect of CMA is presumed to be the result of both its binding to androgen receptors - competitively inhibiting the effect of endogenous testosterone and dihydrotestosterone - and the competitive inhibition of 5alpha-reductase. In this respect, dosing of CMA is crucial; agonistic effects are observed when doses are increased from those optimal for an antagonistic effect.

Chlormadinone acetate has a strong anti-gonadotropic effect, through negative feedback on gonadotropin secretion, and has been used for more than 20 years alone for contraception in arterial risk patients. The clinical and metabolic tolerability of CMA has been demonstrated in numerous clinical studies with duration of treatment of up to 2.5 years.

The more recent application of CMA as an oral contraceptive in combination with EE (Neo Eunomin®, Belara®) has proven highly successful, with studies reporting excellent contraceptive efficacy, high tolerability and adherence due to a good side effect profile and positive effects on preexisting dysmenorrhea, skin and hair conditions.

RELATIVE PRODCTS:
Chlormadinone Acetate           302-22-7
Cinnamic Acid                 621-82-9
Clobetasol Propionate         25122-46-7
Clostebol Acetate         855-19-6
Cortisone Acetate         1950/4/4
Clomiphene Citrate         50-41-9
Cyproterone Acetate         427-51-0
Creatine Phosphate Disodium 922-32-7

 

NITO BIOC CO., LIMITED

Tel: +86-151 5243 9375
Fax: +86-513 5508 6165
QQ:2675661870

Skype: BiocNITO
E-mail: sales@nitobioc.com
Web: www.nitobioc.com
address

Zifeng Technology Parks, Yuanxing Road,  Nantong 226000, Jiangsu, China.

follow us
  •  
© 2015 "NITO BIOC CO., LIMITED"
ORDER CALL
Leave us your details and our manager will contact you at your convenience